about
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.The Role of MicroRNAs in Environmental Risk Factors, Noise-Induced Hearing Loss, and Mental Stress.What has passed is prolog: new cellular and physiological roles of G6PD.Signaling in the Auditory System: Implications in Hair Cell Regeneration and Hearing Function.Recent Advancements in the Regeneration of Auditory Hair Cells and Hearing Restoration
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@ast
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@en
type
label
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@ast
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@en
prefLabel
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@ast
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@en
P2093
P1476
NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
@en
P2093
Francis Rousset
Karl-Heinz Krause
Stephanie Carnesecchi
P304
P356
10.2174/1381612821666151029112421
P50
P577
2015-10-29T00:00:00Z